Identification and Underlying Mechanisms of Immune Cell- and Senescence-Related Biomarkers in Atrial Fibrillation
Abstract
Objective
To investigate the molecular mechanisms of immune cells (ICs)- and senescence-related biomarkers in atrial fibrillation (AF).
Methods
In this study, immune cell-related genes (ICRGs) were obtained using weighted gene co-expression network analysis (WGCNA) based on the GSE2240 dataset. Subsequently, the intersection of ICRGs, senescence-related genes (SRGs), and differentially expressed genes (DEGs) derived from differential expression analysis between AF and sinus rhythm (SR) groups was obtained to screen candidate genes. Biomarkers were further identified using the least absolute shrinkage and selection operator (LASSO) algorithm and validated in the GSE115571 dataset. Gene set enrichment analysis (GSEA), GeneMANIA network construction, molecular regulatory network construction, and molecular docking were performed to investigate the molecular mechanisms of the biomarkers in AF. A total of 8 male Sprague-Dawley rats of 87 weeks old and weighing 632-656 g were randomly assigned to the AF group and the sinus rhythm (SR) group (n = 4 per group). An AF rat model was established. The mRNA expression levels of myosin light chain kinase (MYLK) and insulin-like growth factor binding protein 2 (IGFBP2) in rat myocardial tissue were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR).
Results
Two biomarkers, MYLK and IGFBP2, were identified. GSEA revealed that MYLK was significantly enriched in the olfactory transduction pathway, whereas IGFBP2 was significantly enriched in the extracellular matrix-receptor interaction pathway. The GeneMANIA network demonstrated functional similarity between these biomarkers and 20 other genes. In addition, MYLK was regulated by 28 transcription factors (TFs) and 41 microRNAs (miRNAs), whereas IGFBP2 was regulated by 63 TFs and 4 miRNAs, including TAF1 and MIRT020526. Drug prediction analysis indicated that only MYLK had potential interactions with 3 drugs, among which Tozasertib exhibited the strongest binding affinity to MYLK, with a binding energy of －7.8 kcal/mol. RT-qPCR results showed that IGFBP2 mRNA expression was upregulated and MYLK mRNA expression was downregulated in myocardial tissue of rats in the AF group compared with the SR group (both P < 0.05).
Conclusion
In this study, MYLK and IGFBP2 are identified as AF-related biomarkers, and their potential molecular mechanisms are elucidated, providing new theoretical insights into AF research.
Keywords: Atrial fibrillation, Immune cells, Senescence
Full Text:
PDFReferences
LÜ H L, LIU Y M. Multiparametric echocardiographic assessment for myocardial function in idiopathic ventricular fibrillation patients. J Sun Yat-Sen Univ (Med Sci), 2024, 45(4): 622-630. doi: 10.13471/j.cnki.j.sun. yat-sen.univ(med.sci).20240617.003.
CHEN R X, HAN Y H, ZHAO J D, et al. Study on the influencing factors of new-onset atrial fibrillation after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. J Chengdu Med Coll, 2024, 19(5): 861-863. doi: 10.3969/j.issn.1674-2257.2024.05.026.
KORNEJ J, BÖRSCHEL C S, BENJAMIN E J, et al. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res, 2020, 127(1): 4-20. doi: 10.1161/CIRCRESAHA.120.316340.
LI Y L, XIE P, WU Y, et al. Echocardiographic predictors of left atrial appendage thrombus formation in patients with atrial fibrillation. J Lanzhou Univ (Med Sci), 2022, 48(7): 30-34. doi: 10.13885/j.issn.1000-2812.2022.07.006.
XU R X, SHI J X, WU J C, et al. Association of epicardial adipose tissue and inflammatory factors with atrial fibrillation. J Chongqing Med Univ, 2024, 49(7): 884-889. doi: 10.13406/j.cnki.cyxb.003551.
HUANG M, HUISKES F G, De GROOT N M S, et al. The role of immune cells driving electropathology and atrial fibrillation. Cells, 2024, 13(4): 311. doi: 10.3390/cells13040311.
YUAN X M, GU Q, ZHANG G. Evaluation system for cardiovascular senescence in elderly patients with cardiovascular diseases. Pract J Clin Med, 2017, 14(5): 104-106. doi: 10.3969/j.issn.1672-6170.2017.05.034.
YANG R, YU J M, ZHANG X B, et al. Research progress on molecular mechanism relatedto ventricular remodeling in elderly patients withchronic heart failure. J Clin Med Pract, 2023, 27(23): 139-143. doi: 10. 7619/jcmp.20231891.
CIACCIO E J, COROMILAS J, COSTEAS C A, et al. Sinus rhythm electrogram shape measurements are predictive of the origins and characteristics of multiple reentrant ventricular tachycardia morphologies. J Cardiovasc Electrophysiol, 2004, 15(11): 1293-301. doi: 10.1046/j.1540-8167.2004.03524.x.
LEBLANC F J A, JIN X, KANG K, et al. Atrial fibrillation variant-to-gene prioritization through cross-ancestry eQTL and single-nucleus multiomic analyses. iScience, 2024, 27(9): 110660. doi: 10.1016/j.isci.2024.110660.
XIANG J, SHEN J, ZHANG L, et al. Identification and validation of senescence-related genes in circulating endothelial cells of patients with acute myocardial infarction. Front Cardiovasc Med, 2022, 9: 1057985. doi: 10.3389/fcvm.2022.1057985.
MONACO G, LEE B, XU W, et al. RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep, 2019, 26(6): 1627-1640. e7. doi: 10.1016/j.celrep. 2019.01.041.
ZHANG J, ZHANG B, LI T, et al. Exploring the shared biomarkers between cardioembolic stroke and atrial fibrillation by WGCNA and machine learning. Front Cardiovasc Med, 2024, 11: 1375768. doi: 10.3389/fcvm.2024.1375768.
ZHANG Z, DING J, MI X, et al. Identification of common mechanisms and biomarkers of atrial fibrillation and heart failure based on machine learning. ESC Heart Fail, 2024, 11(4): 2323-2333. doi: 10.1002/ehf2.14799.
TANG N, ZHOU Q, LIU S, et al. Development and trends in research on hypertension and atrial fibrillation: a bibliometric analysis from 2003 to 2022. Medicine (Baltimore), 2024, 103(21): e38264. doi: 10.1097/MD. 0000000000038264.
SZKLARCZYK D, KIRSCH R, KOUTROULI M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res, 2023, 51(D1): D638-D646. doi: 10.1093/nar/gkac1000.
MAJEED A, MUKHTAR S. Protein-protein interaction network exploration using cytoscape. Methods Mol Biol, 2023, 2690: 419-427. doi: 10.1007/978-1-0716-3327-4_32.
KHAPCHAEV A Y, SHIRINSKY V P. Myosin light chain kinase MYLK1: anatomy, interactions, functions, and regulation. Biochemistry (Mosc), 2016, 81(13): 1676-1697. doi: 10.1134/S000629791613006X.
LIU Z L, LI Y, LIN Y J, et al. Aging aggravates aortic aneurysm and dissection via miR-1204-MYLK signaling axis in mice. Nat Commun, 2024, 15(1): 5985. doi: 10.1038/s41467-024-50036-2.
FIRTH S M, BAXTER R C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev, 2002, 23(6): 824-854. doi: 10.1210/er. 2001-0033.
ZHAO Y, CHE Y, LIU Q, et al. Analyses of m6A regulatory genes and subtype classification in atrial fibrillation. Front Cell Neurosci, 2023, 17: 1073538. doi: 10.3389/fncel.2023.1073538.
CHEN Q, WU X F W, TANG J X, et al. A novel extracellular matrix gene-based prognostic model to predict overall survive in patients with glioblastoma. Front Genet, 2022, 13: 851427. doi: 10.3389/fgene.2022. 851427.
BOELMAN M B, HANSEN T V O, SMITH M N, et al. Aortic dissection in a young male with persistent ductus arteriosus and a novel variant in MYLK. Am J Med Genet A, 2024, 194(3): e63458. doi: 10.1002/ajmg.a.63458.
SHI Y, LI J, ZHANG J, et al. Copy number variation of MYLK4 gene and its growth traits of Capra hircus (goat). Anim Biotechnol, 2020, 31(6): 532-537. doi: 10.1080/10495398.2019.1635137.
CARMENA M, EARNSHAW W C. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol, 2003, 4(11): 842-854. doi: 10.1038/nrm1245.
GAO N, HUANG J, HE W, et al. Signaling through myosin light chain kinase in smooth muscles. J Biol Chem, 2013, 288(11): 7596-7605. doi: 10. 1074/jbc.M112.427112.
Refbacks
- There are currently no refbacks.
